Outcomes | NFSD (n = 95) | FSD (n = 175) | ||||
---|---|---|---|---|---|---|
Group A (n = 49) | Group B (n = 46) | p | Group A (n = 63) | Group B (n = 112) | p | |
FDP ± SD (μg/mL) | ||||||
Pre-OP | 3.38 ± 5.38 | 2.20 ± 3.18 | 0.290* | 2.91 ± 4.64 | 2.27 ± 4.35 | 0.436* |
POD1 | 19.13 ± 17.82 | 15.32 ± 11.68 | 0.314* | 21.86 ± 25.87 | 16.70 ± 10.61 | 0.209* |
POD3 | 6.82 ± 2.72 | 6.57 ± 4.72 | 0.796* | 7.29 ± 4.91 | 7.17 ± 4.58 | 0.889* |
POD5 | 11.53 ± 6.58 | 8.41 ± 3.34 | 0.139* | 11.74 ± 6.02 | 10.98 ± 4.53 | 0.597* |
POD7 | 13.99 ± 5.70 | 12.41 ± 3.97 | 0.422* | 13.69 ± 4.34 | 13.60 ± 5.92 | 0.963* |
D-D ± SD (mg/L) | ||||||
Pre-OP | 1.21 ± 2.08 | 0.70 ± 0.86 | 0.218* | 1.08 ± 1.77 | 0.84 ± 1.65 | 0.462* |
POD1 | 8.16 ± 7.73 | 5.73 ± 3.99 | 0.125* | 6.40 ± 3.79 | 6.14 ± 5.55 | 0.777* |
POD3 | 2.54 ± 2.69 | 2.22 ± 1.13 | 0.554* | 2.82 ± 2.82 | 2.47 ± 1.89 | 0.474* |
POD5 | 4.82 ± 4.03 | 3.23 ± 1.86 | 0.213* | 4.90 ± 3.45 | 4.31 ± 1.94 | 0.465* |
POD7 | 5.61 ± 1.85 | 5.17 ± 2.65 | 0.593† | 5.08 ± 3.64 | 5.02 ± 1.37 | 0.953* |
PT ± SD (s) | ||||||
Pre-OP | 13.34 ± 0.78 | 13.25 ± 0.67 | 0.594* | 13.24 ± 0.69 | 13.10 ± 0.81 | 0.322* |
POD1 | 13.80 ± 1.12 | 13.98 ± 0.80 | 0.406* | 13.98 ± 1.63 | 13.89 ± 0.77 | 0.650* |
POD3 | 13.69 ± 0.88 | 13.79 ± 0.84 | 0.631* | 13.47 ± 1.91 | 13.72 ± 1.02 | 0.301* |
POD5 | 13.56 ± 1.01 | 13.51 ± 0.83 | 0.875* | 13.22 ± 0.98 | 13.35 ± 0.86 | 0.565* |
POD7 | 13.52 ± 0.51 | 13.55 ± 0.62 | 0.876* | 12.76 ± 1.93 | 12.89 ± 0.72 | 0.810* |
APTT ± SD (s) | ||||||
Pre-OP | 35.38 ± 4.29 | 37.76 ± 9.94 | 0.228* | 35.40 ± 3.78 | 35.85 ± 3.59 | 0.496* |
POD1 | 36.11 ± 3.07 | 36.63 ± 4.05 | 0.558* | 35.49 ± 3.83 | 35.42 ± 3.22 | 0.902* |
POD3 | 38.57 ± 4.36 | 39.76 ± 6.85 | 0.416* | 38.41 ± 4.64 | 38.52 ± 4.96 | 0.903* |
POD5 | 37.93 ± 8.42 | 39.21 ± 4.50 | 0.494* | 38.59 ± 4.81 | 37.83 ± 5.48 | 0.570* |
POD7 | 35.14 ± 4.59 | 37.82 ± 4.14 | 0.108* | 37.80 ± 4.23 | 36.71 ± 5.57 | 0.546* |